Clinical Trial

Carotid Plaque Imaging Project (CPIP)

Study acronym: CPIP
Recruiting
View on ClinicalTrials.gov →
Summary
The rupture or erosion of an atherosclerotic plaque with thrombosis or embolization often underlie heart attacks and strokes. The early identification of patients with atherosclerotic plaques prone to rupture or erosions, vulnerable plaques (VP), and their treatment before the occurrence of events is, therefore, one of the greatest cardiovascular challenges today. Possible approaches for early detection of VP include imaging techniques allowing visualization of plaque structure, circulating biomarkers and better understanding of the pathophysiologic mechanisms of the disease. In the carotid plaque imaging project the investigators study human atherosclerotic plaques (that are removed by endarterectomy) to disclose their underlying structure and mechanisms, finding possible novel therapeutic targets or markers for VP. The investigators also study plaque structure with imaging methods and try to develop new ways to detect VP using circulating or imaging markers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-18.
Trial Details
NCT Number NCT05821894
Lead Sponsor Lund University
Collaborators: Region Skane, The Swedish Research Council, Swedish Heart Lung Foundation, Skåne University Hospital funds (incl. the Medical Training and Research Agreement/ALF), Swedish Foundation for Strategic Research
Conditions Atherosclerosis, Atherosclerotic Plaque
Enrollment 3,500 participants
Start Date 2005-10-26
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2024-10-15